Press Releases

CatSci announces strategic acquisition of Reach Separations to offer end-to-end separation science support from discovery to manufacture, with the support of Keensight Capital

Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation

Avallano has ann announced the appointment of Michael A. Ibara, PharmD., as Chief Strategy Officer (CSO).

Emmes partners with ILiAD Biotechnologies to Conduct Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pertussis Vaccine

Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies

Biopharma gains a seamless transition from drug discovery through drug product manufacturing

Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility

Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience

AI-powered eClinical Platform, Clinion, announces strategic partnership with eClinical safety solutions provider, Clinevo.

Cresset Successfully Achieves SOC 2 Compliance

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024

ProPharma Recognized as a Top Outsourcing Partner

ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.

Huateng Pharma to Exhibit at CPHI China 2024

Onyx Scientific Aims for European Growth with New BD Hire

Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.

MIB Agents’ Community of Families Has Awarded Over $1.9M in Grants to Research Pediatric Bone Cancer

Leading Pediatric Osteosarcoma Nonprofit to Present $350,000 to 5 Scientists on June 21 to Find Kinder Treatments for Patients

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’

CluePoints Brand Evolution Confirms Commitment to ‘Turning Artificial Intelligence into Human Intelligence’ CluePoints extends its use of AI/ML and continues to find smarter ways to manage clinical trials

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

CluePoints, a leading provider of AI-driven software solutions for Clinical Data Review, receives significant investment for continued growth from EQT

Asgard Therapeutics selects Exothera to bring their viral vector-based immunotherapy candidate AT-108 to clinical trial stage

Exothera has announced that Asgard Therapeutics has selected them to develop and scale-up a manufacturing process for the viral vector-based immunotherapy candidate AT-108, including development of analytical methods, GMP-grade material production, and aseptic filling.

CordenPharma & Certest: A Powerful Partnership Unleashing the Potential of Patented Ionizable Lipids in LNP Formulation

City University of New York Partners with Genestack to Enhance AI readiness of Life Science Data in the Bioconductor Program

Genestack has announced a collaboration with City University of New York (CUNY) to streamline data curation for the BioConductor program, a widely used open-source software project that provides tools for the analysis and comprehension of high-throughput genomic data.

FDA and CluePoints Sign New 3 Year Cooperative Research and Development Agreement to Assess Data Quality using Statistical Modelling and Machine Learning

FDA extends its use of CluePoints to include AI/ML within an automated system to assess data quality in multicenter clinical trials

Syngene launches platform for rapid, enhanced protein production

Ardena appoints Jeremie Trochu as Chief Executive Officer

Ardena has appointed Jeremie Trochu as Chief Executive Officer following the retirement of Harry Christiaens, who will remain on the company's board after 20 years of leadership. Trochu, previously with Catalent, Inc., brings extensive experience in the life sciences and CDMO industry, positioning Ardena for continued growth and international expansion.